| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Spyre Therapeutics, Inc. (SYRE) has 10 insiders with recent SEC Form 4 filings, including 21 buys and 2 sells. SYRE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 581.7K | $60.70M | -15,000 | |
| CFO | 344.9K | $35.99M | -7,500 | |
| Other | 140.0K | $14.61M | - | |
| Dir | 68.6K | $7.16M | - | |
| Dir | 8.0K | $837.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2022 | Alspaugh Jonathan | Chief Financial Officer | Buy | 75,000 | $2.08 | $156,000.00 | +83.0% | -63.5% | -80.9% | |
| Dec 13, 2021 | Shanafelt Armen | Director | Buy | 150,000 | $3.66 | $549,692.38 | +58.3% | -49.9% | -89.7% | |
| Dec 10, 2021 | Quinn Anthony G. | President &CEO | Buy | 53,634 | $3.71 | $198,972.10 | +9.0% | -43.0% | -89.9% | |
| Dec 9, 2021 | Alspaugh Jonathan | Chief Financial Officer | Buy | 50,000 | $3.72 | $186,000.00 | +123.8% | -35.4% | -89.6% | |
| Aug 18, 2021 | Alspaugh Jonathan | Chief Financial Officer | Buy | 40,372 | $6.51 | $262,659.81 | +94.0% | +0.4% | -92.6% | |
| Apr 30, 2020 | Quinn Anthony G. | President &CEO | Buy | 165,000 | $4.75 | $783,750.00 | +44.2% | - | - | |
| Jun 14, 2019 | Quinn Anthony G. | President &CEO | Buy | 31,905 | $6.16 | $196,453.22 | +3.2% | - | - | |
| May 22, 2019 | Quinn Anthony G. | President &CEO | Buy | 26,592 | $6.77 | $180,032.46 | +2.9% | - | - | |
| May 17, 2019 | Quinn Anthony G. | President &CEO | Buy | 18,713 | $6.75 | $126,398.71 | +1.7% | - | - | |
| Sep 27, 2018 | Schuchart Aaron | Chief Business Officer | Sell | 6,000 | $9.50 | $57,005.00 | -35.5% | - | - |